Literature DB >> 27617721

Segmental neurofibromatosis and cancer: report of triple malignancy in a woman with mosaic Neurofibromatosis 1 and review of neoplasms in segmental neurofibromatosis.

Philip R Cohen1.   

Abstract

BackgroundSegmental neurofibromatosis, referred to as mosaic neurofibromatosis 1, patients present with neurofibromas or café au lait macules or both in a unilateral segment of the body.PurposeA woman with segmental neurofibromatosis and triple cancer (renal cell carcinoma, mixed thyroid carcinoma, and lentigo maligna) is described and cancers observed in patients with segmental neurofibromatosis are reviewed.MethodsPubMed was used to search the following terms, separately and in combination: cancer, malignancy, mosaic, neoplasm, neurofibroma, neurofibromatosis, segment, segmental, tumor.ResultsMalignancy (13 cancers) has been observed in 11 segmental neurofibromatosis patients; one patient had three different cancers. The most common neoplasms were of neural crest origin {malignant peripheral nerve sheath tumor (3 patients) and melanoma (3 patients)] and gastrointestinal tract origin [colon (1 patient) and gastric (1 patient)]. Breast cancer, Hodgkin lymphoma, lung cancer, kidney cancer, and thyroid cancer each occurred in one patient.ConclusionsSimilar to patients with von Recklinghausen neurofibromatosis 1, individuals with segmental neurofibromatosis also have a genodermatosis-associated increased risk of developing cancer.

Entities:  

Mesh:

Year:  2016        PMID: 27617721

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  7 in total

Review 1.  Breast Cancer and Multiple Primary Malignant Tumors: Case Report and Review of the Literature.

Authors:  Alessandro De Luca; Federico Frusone; Massimo Vergine; Rosario Cocchiara; Giuseppe La Torre; Laura Ballesio; Massimo Monti; Maria Ida Amabile
Journal:  In Vivo       Date:  2019 Jul-Aug       Impact factor: 2.155

2.  [Rare form of a segmental neurofibromatosis with giant plexiform neurofibroma].

Authors:  Robin Reschke; Marketa Kadlecova; Sonja Grunewald; Mirjana Ziemer
Journal:  Hautarzt       Date:  2019-08       Impact factor: 0.751

3.  [Segmental neurofibromatosis].

Authors:  G Wagner; V Meyer; M M Sachse
Journal:  Hautarzt       Date:  2018-06       Impact factor: 0.751

4.  Pigmented (melanotic) diffuse neurofibroma of the back in neurofibromatosis type 1.

Authors:  Reinhard E Friedrich; Christian Hagel
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2018-08-03

5.  Chronic Lymphocytic Leukemia in Neurofibromatosis Type 1 Patients: Case Report and Literature Review of a Rare Occurrence.

Authors:  Philip R Cohen
Journal:  Cureus       Date:  2021-04-02

Review 6.  Clinical features and disease severity in patients with mosaic neurofibromatosis type 1: a single-center study and literature review.

Authors:  C Ejerskov; M Raundahl; P A Gregersen; M M Handrup
Journal:  Orphanet J Rare Dis       Date:  2021-04-14       Impact factor: 4.123

Review 7.  Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review.

Authors:  Ruth T Casey; Anne Y Warren; Jose Ezequiel Martin; Benjamin G Challis; Eleanor Rattenberry; James Whitworth; Katrina A Andrews; Thomas Roberts; Graeme R Clark; Hannah West; Philip S Smith; France M Docquier; Fay Rodger; Vicki Murray; Helen L Simpson; Yvonne Wallis; Olivier Giger; Maxine Tran; Susan Tomkins; Grant D Stewart; Soo-Mi Park; Emma R Woodward; Eamonn R Maher
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.